13 years 
of Publication, 100k+ Stories, 30+ Countries
13 years
Search
The Latest News from All Areas of Deals
Clifford Chance advises Abrdn on its investment into a series B funding round for micro-mobility company Dott
International law firm Clifford Chance has advised Aberdeen Asset Managers Limited ("Abrdn") on its direct investment into micro-mobility company amTransit…
Latham & Watkins Advises Astorg, Nordic Capital, and Portfolio Company Clario on Divestiture of Clario’s Drug Safety Solutions to Stanley Capital Partners
The parties have announced the divestiture by Clario of its Drug Safety and Pharmacovigilance Services Solutions (DSS) division to funds…
Latham & Watkins Advises Vitol in Connection to the Formation of VTX Energy Partners
Vitol and the management of ATX Energy Partners, LLC have announced the formation of VTX Energy Partners, LLC. VTX will…
False Claims Act remains a key DOJ enforcement tool, warns new FCA Guide
Washington, D.C., 2 February 2022 – While the transition to the Biden administration has ushered in many changes—including new policies…
Kirkland Advises Maverick on $440 Million Purchase of Permian Basin Producing Properties
Kirkland & Ellis counseled Maverick Natural Resources, LLC on its definitive agreement to acquire certain producing properties in the Permian…
Latham & Watkins Advises Homology Medicines, Inc. in a Newly Formed AAV Manufacturing and Innovation Business with Oxford Biomedica
Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Group”), a leading gene and cell therapy group, and Homology Medicines, Inc.…
